Global Erlotinib Hydrochloride Market Survey and Trend Research 2018

January 2018 | 134 pages | ID: G74C508C26FEN
99Strategy

Abstracts

Summary

Erlotinib Hydrochloride is an anticancer drug from protein kinase inhibitors pharmacological group. This medication is used for the treatment of non-small cell lung cancer (NSCLC), locally advanced, unresectable or metastatic pancreatic cancer, and several other types of cancer. It is usually given after other cancer medicines have been tried without success. Erlotinib acts on the epidermal growth factor receptor (EGFR), and it works by interfering with the growth of cancer cells and slows their spread in the body

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makesA scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (Roche, Cipla, Mylan, Teva, Glenmark Pharmaceuticals, Glenmark Pharmaceuticals, Beacon Pharmaceuticals, Raichem Lifesciences, United Biotech, CJ Corporation, Vivimed Labs, Boryung Pharmaceutical, Taj Pharmaceuticals, Pharmascience, Natco Pharma, Intas Pharmaceuticals, RPG Life Sciences, Pharmascience, Schwarz Pharma, Dr. Reddy’s Laboratories, Glenmark Pharmaceuticals, Chugai Pharmaceutical, DKSH, Firma Chun Cheong, Kremers Urban Pharmaceuticals, Ortat, Zuellig Pharma etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Erlotinib Hydrochloride Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 ERLOTINIB HYDROCHLORIDE MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 Roche (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Cipla (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Mylan (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Teva (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Glenmark Pharmaceuticals (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Glenmark Pharmaceuticals (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Beacon Pharmaceuticals (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Raichem Lifesciences (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 United Biotech (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 CJ Corporation (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 Vivimed Labs (Company Overview, Sales Data etc.)
4.12 Boryung Pharmaceutical (Company Overview, Sales Data etc.)
4.13 Taj Pharmaceuticals (Company Overview, Sales Data etc.)
4.14 Pharmascience (Company Overview, Sales Data etc.)
4.15 Natco Pharma (Company Overview, Sales Data etc.)
4.16 Intas Pharmaceuticals (Company Overview, Sales Data etc.)
4.17 RPG Life Sciences (Company Overview, Sales Data etc.)
4.18 Pharmascience (Company Overview, Sales Data etc.)
4.19 Schwarz Pharma (Company Overview, Sales Data etc.)
4.20 Dr. Reddy’s Laboratories (Company Overview, Sales Data etc.)
4.21 Glenmark Pharmaceuticals (Company Overview, Sales Data etc.)
4.22 Chugai Pharmaceutical (Company Overview, Sales Data etc.)
4.23 DKSH (Company Overview, Sales Data etc.)
4.24 Firma Chun Cheong (Company Overview, Sales Data etc.)
4.25 Kremers Urban Pharmaceuticals (Company Overview, Sales Data etc.)
4.26 Ortat (Company Overview, Sales Data etc.)
4.27 Zuellig Pharma (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table GLOBAL ERLOTINIB HYDROCHLORIDE MARKET 2012-2017, BY TYPE, IN USD MILLION
Table Global Erlotinib Hydrochloride Market 2012-2017, by Type, in Volume
Table Global Erlotinib Hydrochloride Market Forecast 2018-2023, by Type, in USD Million
Table Global Erlotinib Hydrochloride Market Forecast 2018-2023, by Type, in Volume
Table Roche Overview List
Table Erlotinib Hydrochloride Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cipla Overview List
Table Erlotinib Hydrochloride Business Operation of Cipla (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mylan Overview List
Table Erlotinib Hydrochloride Business Operation of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Overview List
Table Erlotinib Hydrochloride Business Operation of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Glenmark Pharmaceuticals Overview List
Table Erlotinib Hydrochloride Business Operation of Glenmark Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Glenmark Pharmaceuticals Overview List
Table Erlotinib Hydrochloride Business Operation of Glenmark Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Beacon Pharmaceuticals Overview List
Table Erlotinib Hydrochloride Business Operation of Beacon Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Raichem Lifesciences Overview List
Table Erlotinib Hydrochloride Business Operation of Raichem Lifesciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table United Biotech Overview List
Table Erlotinib Hydrochloride Business Operation of United Biotech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CJ Corporation Overview List
Table Erlotinib Hydrochloride Business Operation of CJ Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Vivimed Labs Overview List
Table Erlotinib Hydrochloride Business Operation of Vivimed Labs (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boryung Pharmaceutical Overview List
Table Erlotinib Hydrochloride Business Operation of Boryung Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Taj Pharmaceuticals Overview List
Table Erlotinib Hydrochloride Business Operation of Taj Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pharmascience Overview List
Table Erlotinib Hydrochloride Business Operation of Pharmascience (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Natco Pharma Overview List
Table Erlotinib Hydrochloride Business Operation of Natco Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Intas Pharmaceuticals Overview List
Table Erlotinib Hydrochloride Business Operation of Intas Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table RPG Life Sciences Overview List
Table Erlotinib Hydrochloride Business Operation of RPG Life Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pharmascience Overview List
Table Erlotinib Hydrochloride Business Operation of Pharmascience (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Schwarz Pharma Overview List
Table Erlotinib Hydrochloride Business Operation of Schwarz Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dr. Reddy’s Laboratories Overview List
Table Erlotinib Hydrochloride Business Operation of Dr. Reddy’s Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Glenmark Pharmaceuticals Overview List
Table Erlotinib Hydrochloride Business Operation of Glenmark Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Chugai Pharmaceutical Overview List
Table Erlotinib Hydrochloride Business Operation of Chugai Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table DKSH Overview List
Table Erlotinib Hydrochloride Business Operation of DKSH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Firma Chun Cheong Overview List
Table Erlotinib Hydrochloride Business Operation of Firma Chun Cheong (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Kremers Urban Pharmaceuticals Overview List
Table Erlotinib Hydrochloride Business Operation of Kremers Urban Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ortat Overview List
Table Erlotinib Hydrochloride Business Operation of Ortat (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Zuellig Pharma Overview List
Table Erlotinib Hydrochloride Business Operation of Zuellig Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Erlotinib Hydrochloride Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Erlotinib Hydrochloride Sales Revenue Share, by Companies, in USD Million
Table Global Erlotinib Hydrochloride Sales Volume 2012-2017, by Companies, in Volume
Table Global Erlotinib Hydrochloride Sales Revenue Share, by Companies in 2017, in Volume
Table Erlotinib Hydrochloride Demand 2012-2017, by Application, in USD Million
Table Erlotinib Hydrochloride Demand 2012-2017, by Application, in Volume
Table Erlotinib Hydrochloride Demand Forecast 2018-2023, by Application, in USD Million
Table Erlotinib Hydrochloride Demand Forecast 2018-2023, by Application, in Volume
Table Global Erlotinib Hydrochloride Market 2012-2017, by Region, in USD Million
Table Global Erlotinib Hydrochloride Market 2012-2017, by Region, in Volume
Table Erlotinib Hydrochloride Market Forecast 2018-2023, by Region, in USD Million
Table Erlotinib Hydrochloride Market Forecast 2018-2023, by Region, in Volume

List Of Figures

LIST OF FIGURES

Figure Erlotinib Hydrochloride Industry Chain Structure
Figure Global Erlotinib Hydrochloride Market Growth 2012-2017, by Type, in USD Million
Figure Global Erlotinib Hydrochloride Market Growth 2012-2017, by Type, in Volume
Figure Global Erlotinib Hydrochloride Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Erlotinib Hydrochloride Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region